- Home
- AUUD vs SPRC Comparison
AUUD vs SPRC Comparison
Compare AUUD & SPRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUUD
- SPRC
- Stock Information
- Founded
- AUUD 2012
- SPRC 2004
- Country
- AUUD United States
- SPRC Israel
- Employees
- AUUD N/A
- SPRC N/A
- Industry
- AUUD Computer Software: Prepackaged Software
- SPRC Biotechnology: Pharmaceutical Preparations
- Sector
- AUUD Technology
- SPRC Health Care
- Exchange
- AUUD Nasdaq
- SPRC Nasdaq
- Market Cap
- AUUD 2.9M
- SPRC 3.4M
- IPO Year
- AUUD 2021
- SPRC N/A
- Fundamental
- Price
- AUUD $3.98
- SPRC $7.00
- Analyst Decision
- AUUD
- SPRC
- Analyst Count
- AUUD 0
- SPRC 0
- Target Price
- AUUD N/A
- SPRC N/A
- AVG Volume (30 Days)
- AUUD 115.0K
- SPRC 18.6K
- Earning Date
- AUUD 08-06-2025
- SPRC 02-15-2025
- Dividend Yield
- AUUD N/A
- SPRC N/A
- EPS Growth
- AUUD N/A
- SPRC N/A
- EPS
- AUUD N/A
- SPRC N/A
- Revenue
- AUUD N/A
- SPRC $1,306,000.00
- Revenue This Year
- AUUD N/A
- SPRC N/A
- Revenue Next Year
- AUUD N/A
- SPRC N/A
- P/E Ratio
- AUUD N/A
- SPRC N/A
- Revenue Growth
- AUUD N/A
- SPRC N/A
- 52 Week Low
- AUUD $2.88
- SPRC $4.14
- 52 Week High
- AUUD $31.62
- SPRC $37.59
- Technical
- Relative Strength Index (RSI)
- AUUD 42.19
- SPRC 56.36
- Support Level
- AUUD $3.93
- SPRC $6.25
- Resistance Level
- AUUD $5.02
- SPRC $7.17
- Average True Range (ATR)
- AUUD 0.72
- SPRC 0.55
- MACD
- AUUD -0.12
- SPRC 0.04
- Stochastic Oscillator
- AUUD 1.49
- SPRC 69.79
About AUUD Auddia Inc.
Auddia Inc is a technology company that is engaged in radio broadcasts and streaming audio content digitally. Its products includes Auddia App which is a subscription-based commercial-free AM/FM software application, and Vodacast an interactive podcasting platform and application. The company generates revenue through subscription fees from customers accessing the company's cloud-based computing services and advertisement services.
About SPRC SciSparc Ltd.
SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.